MYOD1 anticorps (N-Term)
Aperçu rapide pour MYOD1 anticorps (N-Term) (ABIN1737175)
Antigène
Voir toutes MYOD1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-150, N-Term
-
Specificité
- Reacts with human and mouse MyoD
-
Purification
- Antigen affinity purified
-
Immunogène
- A genomic peptide made to an N-terminal region of the human MyoD1 protein (within residues 1-150).
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
ICC(1:100) IF(1:100) WB(1:5000) -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.58 mg/mL
-
Buffer
- PBS, glycerol 50 % , BSA 0.1 %, Sodium azide 0.05 %
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Short term storage at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
-
Date de péremption
- 6 months
-
-
- MYOD1 (Myogenic Differentiation 1 (MYOD1))
-
Autre désignation
- MyoD1
-
Sujet
- In muscle cell development and differentiation, MYOD1 is a key transcription factor regulating myogenesis. In skeletal muscle, MYOD1 works in tandem with PC4 to promote MEF2C transcription, and thus regeneration of muscle following injury. MYOD1 also influences normal muscle cell formation. Unsurprisingly, MYOD1 is then associated with several diseases of muscle groups, including infantile myofibroma, rhabdomyosarcoma, ulcerative colitis, and sclerosis. MYOD1 is also found in atypical cells of orbital pleomorphic liposarcoma in children.
-
UniProt
- P15172
-
Pathways
- Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development
Antigène
-